Hunt prioritises elderly and cancer
October 10, 2012Sales and Marketing
Health secretary Jeremy Hunt yesterday put the care of the elderly at the centre of his vision for public health …
AZ licences renal disease compound
October 9, 2012Research and Development, Sales and Marketing Ardelyx, AstraZeneca, NHE3
AstraZeneca has signed an agreement giving it worldwide exclusive rights to California-based Ardelyx’s NHE3 inhibitor programme targeting liver and kidney …
Catalent and Parexel forge partnership
October 9, 2012Manufacturing and Production Catalent, Parexel
Catalent Pharma Solutions has formed an alliance with Parexel in a further boost to its aspirations in clinical trial material …
Novasep announces changes at the top
October 9, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development Novasep, Patrick Glaser, Roger-Marc Nicoud, manufacturing
Novasep has announced the appointment of Roger-Marc Nicoud, founder and chief executive, as non-executive chairman of the Board. The manufacturing …
DSM joins forces with Almac for biocatalysis
October 9, 2012Manufacturing and Production Almac, DSM
DSM Pharmaceutical Products has teamed up with Almac to offer biocatalysis services to customers in the drug industry. By working …
Olympus Biotech launches CMO services
October 9, 2012Manufacturing and Production CMO, Japan, Olympus
US-based Olympus Biotech has launched a contract manufacturing organisation (CMO) operation to complement its current focus on regenerative medicines. The …
Dr Reddy’s grows UK manufacturing base
October 9, 2012Manufacturing and Production CPS, Dow Pharma, Dr Reddy's, Mirfield
India’s Dr Reddy’s Laboratories has said it plans to increase its manufacturing operations in the UK with a round of …
Scotland ‘no’ to Avastin
October 9, 2012Sales and Marketing NICE, Roche, Scotland, avastin
Roche has slammed the Scottish Medicines Consortium (SMC)’s decision not to recommend Avastin for women with advanced ovarian cancer in …
Digital Pharma: what should we talk about?
October 8, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer, Facebook, Pfizer, digital pharma, social media, twiiter
The received wisdom today among the ‘digirati’ is that the pharmaceutical industry must join in the online conversation, and to …
Takeda to buy LigoCyte for $60 million
October 8, 2012Sales and Marketing LigoCyte, Takeda, norovirus
Takeda Pharmaceutical Company is to pay $60 million upfront to buy private US biopharma firm LigoCyte Pharmaceuticals in the next …
Sanofi’s Zaltrap data published
October 8, 2012Research and Development, Sales and Marketing Erbitux, Sanofi, Stivarga, Zaltrap, avastin
Detailed data from the Phase III trial of Sanofi’s newly-licenced anti-VEGF cancer drug Zaltrap, co-marketed with Regeneron, has been published. …
Chiltern announces new chief executive
October 8, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Jim Esinhart, chiltern
Contract research organisation Chiltern International has announced a successor to chief executive Glenn Kerkhof, who is stepping down to be …
NICE does Lucentis U-turn
October 5, 2012Sales and Marketing Lucentis, NICE, Novartis, Roche, avastin
NICE has done a U-turn over its previous verdict on Novartis’ Lucentis, now recommending the drug in draft guidance to …
Vernon named Digital Pioneer at PM Society awards
October 5, 2012Medical Communications Creative Lynx, GSK, PM Society Digital Awards, digital
A range of innovative digital programmes created by UK pharma companies and agencies were recognised at last night’s PM Society …
NHS under fire for ‘misdiagnosis’
October 5, 2012Sales and Marketing BHIVA, HIV, NHS
Patients with HIV infections are going unnoticed by the NHS while those with rare diseases are often being misdiagnosed. These …
Appointments and moves at the BIA
October 5, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, BioIndustry Association
The BioIndustry Association (BIA) has appointed Harren Jhoti and Will West to its Board of directors at its Annual General …
Louise Tamblin rejoins Kantar Health
October 4, 2012Kantar Health, Louise Tamblin
Healthcare-focused consultancy and marketing firm Kantar Health has named Louise Tamblin as group director. Most recently Tamblin was head of …
NHS patient care ‘will worsen’
October 4, 2012Sales and Marketing A&E, MRSA, NHS, king's fund
Patient care will worsen over the next few years and the NHS will not meet its £20 billion productivity target …
Sanofi acquires leading Colombian firm
October 4, 2012Sales and Marketing Columbia, Genfar, Latin America, Sanofi
Sanofi is expanding its presence in Latin American with the acquisition of a Colombian pharma company. Genfar is headquartered in …
GW Pharmaceuticals hires chief operating officer
October 4, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Chris Tovey, GW Pharmaceuticals
GW Pharmaceuticals has announced the appointment of Christopher John Tovey to the newly created position of chief operating officer. Tovey, …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
